Ex Parte Yoder et al - Page 8



              Appeal No. 2004-0647                                                                Page 8                
              Application No. 09/941,965                                                                                
                     Claims 1-4 stand rejected under 35 U.S.C. § 103 as unpatentable over Kempf.                        
              Kempf describes the effect of pepsin treatment at pH 4 and 37°C on the infectivity of                     
              several enveloped viruses in intravenous immunoglobulin preparations.  “[T]o study the                    
              influence of pepsin treatment on [virus] inactivation[,]” Kempf “spiked IgG solutions with                
              VSV [(vesicular stomatitis virus)] in the presence or absence of pepsin . . . These                       
              solutions were then adjusted to various pH values ranging from 3.7 to 7.4 and                             
              incubated for 16 hrs at 37°C” (Kempf, page 425).  Figure 3 (Kempf, page 425)                              
              illustrates the results of an 8 hour time course of VSV inactivation in the presence of                   
              pepsin at pH 4 and 37°C.  The time-response curve shows that “inactivation of VSV at                      
              low pH in the presence of pepsin is accomplished within 7 to 8 hours” (id., page 426).                    
                     According to the examiner, “claim 1 differs from [Kempf] . . . in that the acid                    
              hydrolyzed fraction has been heated for from 15 minutes to 1 hour” (Answer, page 4);                      
              and claim 2 differs . . . [in] that the acid hydrolyzed IgG fraction has been hydrolyzed                  
              with from 0.1N to 0.2N acid” (id., page 5).  However, the examiner concluded that “one                    
              of ordinary skill in the art . . . would have been motivated”  to “treat[ ] an immunoglobulin             
              solution with acid pH for 1 hour” “because Kempf [ ] teach[es] that treating any IgG                      
              solutions at pH 4 and [ ] heating at 37°C for as little as one hour is useful to inactivate a             
              variety of envelope viruses” (id.).  With respect to “[t]he recitation of centrifuged and                 
              decanted in claim 1,” the examiner asserts that the recitation “has no patentable weight                  
              because a product is a product, irrespective of how it is made” (id.).  Alternatively, the                
              examiner asserts “it is within the purview of one [ ] skilled in the art . . . to separate any            
              precipitate in a solution by centrifugation and decanting” (id.).                                         
                     To the extent the examiner argues that the claims’ “centrifuged and decanted”                      
              requirement is of no importance, we disagree.  On the one hand, the examiner has not                      



Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007